Deniz Ozmen

Istanbul, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Citrullinated Histone 3 as a Marker of NETosis at Opposite Ends of Hemostasis: Evidence From Thrombosis-Prone MPN and Bleeding-Prone Hemophilia.

Citrullinated Histone 3 as a Marker of NETosis at Opposite Ends of Hemostasis: Evidence From Thrombosis-Prone MPN and Bleeding-Prone Hemophilia.

Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Published: June 22, 2026

Evaluation of the frequency, risk factors, and outcomes of splanchnic vein thrombosis in myeloproliferative neoplasms: a retrospective cohort study.

Evaluation of the frequency, risk factors, and outcomes of splanchnic vein thrombosis in myeloproliferative neoplasms: a retrospective cohort study.

Journal: Journal of thrombosis and thrombolysis

Published: April 14, 2026

A survey on the management of chronic myeloid leukemia in chronic phase from the perspectives of both patients and physicians.

A survey on the management of chronic myeloid leukemia in chronic phase from the perspectives of both patients and physicians.

Journal: Annals of hematology

Published: April 12, 2026

Real-world data on the use of asciminib in chronic-phase chronic myeloid leukemia after two or more prior tyrosine kinase inhibitors: Results of the Turkish managed access program along with a literature review.

Real-world data on the use of asciminib in chronic-phase chronic myeloid leukemia after two or more prior tyrosine kinase inhibitors: Results of the Turkish managed access program along with a literature review.

Journal: Leukemia research

Published: February 01, 2026

Restless legs syndrome in chronic myeloid leukemia: an overlooked condition with a significant impact on health-related quality of life.

Restless legs syndrome in chronic myeloid leukemia: an overlooked condition with a significant impact on health-related quality of life.

Journal: Annals of hematology

Published: December 11, 2025

Late Postoperative Persistent Hemorrhage Following Müller's Muscle-Conjunctival Resection: Management With Tranexamic Acid.

Late Postoperative Persistent Hemorrhage Following Müller's Muscle-Conjunctival Resection: Management With Tranexamic Acid.

Journal: The Journal of craniofacial surgery

Published: October 25, 2025

Recurrent Epistaxis Immediate Following Upper Blepharoplasty: Treatment with Tranexamic Acid.

Recurrent Epistaxis Immediate Following Upper Blepharoplasty: Treatment with Tranexamic Acid.

Journal: The Journal of craniofacial surgery

Published: September 14, 2025

Evaluation of DNA methylation-based age prediction accuracy in leukemia patients using a six-CpG model trained on healthy blood.

Evaluation of DNA methylation-based age prediction accuracy in leukemia patients using a six-CpG model trained on healthy blood.

Journal: Forensic science, medicine, and pathology

Published: September 09, 2025

Arterial Thrombosis in Patients with Primary Immune Thrombocytopenia: A Nationwide Study

Arterial Thrombosis in Patients with Primary Immune Thrombocytopenia: A Nationwide Study

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: August 27, 2025

Is splenectomy one of the contributory factors to pulmonary hypertension? An analysis of splenectomized hemolytic anemia and immune thrombocytopenia patients.

Is splenectomy one of the contributory factors to pulmonary hypertension? An analysis of splenectomized hemolytic anemia and immune thrombocytopenia patients.

Journal: Annals of hematology

Published: March 03, 2025

Retrospective Study to Compare Outcomes in 159 Patients Undergoing First Autologous Stem Cell Transplantation for Myeloma Treated with Melphalan 140 mg/m² or 200 mg/m².

Retrospective Study to Compare Outcomes in 159 Patients Undergoing First Autologous Stem Cell Transplantation for Myeloma Treated with Melphalan 140 mg/m² or 200 mg/m².

Journal: Annals of transplantation

Published: February 11, 2025

Extramedullary disease in multiple myeloma at diagnosis and over the course of the disease.

Extramedullary disease in multiple myeloma at diagnosis and over the course of the disease.

Journal: International journal of hematology

Published: November 06, 2024

Showing 1-12 of 23

Last Updated: 09/26/2026